grade
pharmaceutical primary standard
API family
ritonavir
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
mixture
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Ritonavir Related Compounds Mixture USP reference standard suitable for use in specified USP compendial tests and assays.
Also used to prepare system suitability stock, system suitability, and identity solution for impurity analysis by using the liquid chromatography method and UV detector according to the given below monographs of United States Pharmacopeia (USP):
Also used to prepare system suitability stock, system suitability, and identity solution for impurity analysis by using the liquid chromatography method and UV detector according to the given below monographs of United States Pharmacopeia (USP):
- Lopinavir and Ritonavir Tablets
- Ritonavir Tablets
- Ritonavir
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
Sales restrictions may apply.
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral
存储类别
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Ritonavir
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 37(4), 3912-3912 (2020)
Lopinavir and Ritonavir Tablets
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 43(4), 2670-2670 (2013)
Ritonavir Tablets
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 43(4), 3920-3920 (2013)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持